AB-1005 gene therapy placed on fast track by regulators in US, UK
AskBio’s investigational gene therapy AB-1005 has been granted fast-track designation for Parkinson’s disease by the U.S. Food and…
Articles by Andrea Lobo
Anew Medical to advance development of Klotho gene therapy
Anew Medical said it will advance clinical development of its Klotho gene therapy program to prevent or stop…
MJFF $1.49M grant to advance preclinical research into KLS-13019
Kannalife Sciences has been awarded a $1.49 million grant from The Michael J. Fox Foundation (MJFF) to support…
Platform launched for sharing brain samples in Parkinson’s research
The Aligning Science Across Parkinson’s (ASAP) initiative has launched a data-sharing platform that will make data on human brain…
FDA OKs Parkinson’s clinical trial to test NouvNeu001 cell therapy
The U.S. Food and Drug Administration (FDA) has given Iregene Therapeutics the green light to launch a clinical trial…
OneRF ablation system gets ICD-10-PCS CMS procedure code
NeuroOne Medical Technologies said the Centers for Medicare and Medicaid Services (CMS) granted a new ICD-10-PCS code to…
Precision MRI system being used in trial of Parkinson’s stem cell therapy
A magnetic resonance imaging (MRI)-guided approach known as the ClearPoint Navigation System is being used in a Phase 1/2a clinical…
Dopamine signaling linked to emotion recognition, study finds
Researchers at the University of Birmingham have shown that reducing dopamine signaling in the brain can impair people’s ability to…
MJFF, Merck partner on service for biomarker detection in Parkinson’s
Merck, in collaboration with the Michael J. Fox Foundation for Parkinson’s Research (MJFF), is providing a service to the…
Phase 2 trial of risvodetinib for Parkinson’s now fully enrolled
Patient enrollment is now complete in a Phase 2 trial that’s assessing the safety and efficacy of oral risvodetinib,…